Trademark: 87793892
Status Date
Monday, May 22, 2023
Filing Date
Monday, February 12, 2018
Published for Opposition
Tuesday, February 12, 2019
Abandoned Date
Monday, May 22, 2023
5 pharmaceuticals for use in connection with oncology, ophthalmology, neurology, gastrointestinal conditions, inflammation, dermatology, infectious diseases and metabolic diseases
May 22, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
May 22, 2023
Abandonment - After Inter Partes Decision
May 22, 2023
Opposition Terminated No. 999999
May 22, 2023
Opposition Sustained No. 999999
Aug 9, 2019
Opposition Instituted No. 999999
Mar 13, 2019
Extension Of Time To Oppose Received
Feb 12, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 12, 2019
Published For Opposition
Jan 23, 2019
Notification Of Notice Of Publication E-Mailed
Jan 7, 2019
Assigned To Lie
Dec 12, 2018
Approved For Pub - Principal Register
Dec 8, 2018
Teas/Email Correspondence Entered
Dec 7, 2018
Correspondence Received In Law Office
Dec 7, 2018
Teas Response To Office Action Received
Jun 7, 2018
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jun 7, 2018
Examiner's Amendment/Priority Action E-Mailed
Jun 7, 2018
Combined Examiner's Amendment/Priority Action Automatic Entry
Jun 7, 2018
Examiners Amendment And/Or Priority Action - Completed
May 29, 2018
Assigned To Examiner
Feb 20, 2018
New Application Office Supplied Data Entered
Feb 15, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
